Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway. (Q48121718)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 October 2017

Language	Label	Description	Also known as
English	Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway.	scientific article published on 26 October 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

0 references

neoplastic stem cells

1 reference

based on heuristic

inferred from title

Abdelilah Aboussekhra

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

author name string

Syed S Islam

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Ibtehaj Al-Sharif

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Ahlam Sultan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Amer Al-Mazrou

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Adnane Remmal

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

publication date

24 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Molecular Carcinogenesis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

57

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

333-346

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Triple negative breast cancer: looking for the missing link between biology and treatments

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Triple-Negative Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cancer stem cells and chemoresistance: The smartest survives the raid

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cisplatin in cancer therapy: molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cellular processing of platinum anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Differential marker expression by cultures rich in mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

ALDH1 as a functional marker of cancer stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Combination of phenylpropanoids with 5-fluorouracil as anti-cancer agents against human cervical cancer (HeLa) cell line.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cisplatin induces differentiation of breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Breast cancer stem cells: current advances and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Tackling the cancer stem cells - what challenges do they pose?

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

NF-κB, stem cells and breast cancer: the links get stronger

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Interleukin-8 in breast cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Inflammatory signaling pathways in self-renewing breast cancer stem cells.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Cytokines driving breast cancer stemness

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-κB and MAPK pathways

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22758

21 January 2018

Identifiers

10.1002/MC.22758

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29073729%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48121718&oldid=1494150327"